pharmacy
1 is administered parenterally
2 may be administered twice daily
3 is highly likely to cause cerebral oedema
A 1, 2, 3
B 1, 2 only
C 2, 3 only
D 1 only
E 3 only
Depo-Medrone is?
1 is administered parenterally
2 may be administered twice daily
3 is highly likely to cause cerebral oedema
A 1, 2, 3
B 1, 2 only
C 2, 3 only
D 1 only
E 3 only
D is the answer and the winners are Solace and Area.
Details below:
Depo-Medrone is presented as an aqueous suspension that can be administered either by deep intramuscular injection into the gluteal muscle or by intraarticular or intrasynovial injection for rheumatic disease. Administration can
be repeated after 2–3 weeks or, for rheumatic disease, at intervals of 7–35
days. Corticosteroids, including methylprednisolone, can be used in the
management of raised intracranial pressure or in cerebral oedema resulting
from malignancy
A
A
B
D
D